BioStem Technologies (OTCMKTS:BSEM) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

BioStem Technologies (OTCMKTS:BSEM) posted its earnings results on Tuesday. The company reported 0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of 0.31 by 0.01, Zacks reports. The company had revenue of 82.56 million during the quarter, compared to analyst estimates of 78.22 million.

BioStem Technologies Trading Down 25.5 %

OTCMKTS BSEM opened at 17.41 on Friday. The stock has a market cap of $289.35 million, a P/E ratio of 34.35 and a beta of -0.36. The company’s fifty day simple moving average is 13.28 and its 200-day simple moving average is 10.64. BioStem Technologies has a 52 week low of 2.34 and a 52 week high of 28.26.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.